A few weeks ago many avid market watchers expected the bull run to continue well into 2025 but now they’re not so certain.

Latino Republican lawmakers who approve of Trump are toeing a fine line between supporting his immigration crackdown and ...

Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...

From soaring drug expenses in the Great Plains to rising supply costs in the West, regional disparities highlight the unique pressures facing hospital leaders. As labor shortages persist, supply ...

President Donald Trump’s sweeping tariff threats have been touch and go. As it stands currently, the 25 percent tax on goods ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

President Donald Trump in January ordered federal workers back to the office full time, but some workers say they don't have a desk or an office to go back to.

Alzheimer’s disease is the most common form of dementia, which is a general term for the loss of memory and intellectual abilities. Alzheimer’s disease is fatal and there is no cure. It is a ...

President Donald Trump took office with a promise to “immediately bring prices down.” But conquering inflation is tricky, and ...

The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...

As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...